Ratings by Brookline Capital Markets (Leah Rush Cann)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Marker Therapeutics | MRKR | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Marker Therapeutics | MRKR | New Coverage | Buy (N/A) |
1.77 (1.68) |
-5.08% | Details | |
| 1/6/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2025 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2024 | Exelixis | EXEL | New Coverage | Buy (N/A) |
33.82 (57.08) |
68.78% | Details | |
| 12/23/2024 | Exelixis | EXEL | New Coverage | Buy (N/A) |
33.29 (33.82) |
1.59% | Details | |
| 11/13/2024 | Syros Pharmaceuticals | SYRS | Downgrade | Hold (Buy) |
2.73 (0.12) |
-95.6% | Details | |
| 9/13/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | MEI Pharma | MEIP | Downgrade | Hold (Buy) |
2.86 (3.07) |
7.34% | Details | |
| 6/27/2024 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2024 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2024 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2023 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | SQZ Biotechnologies Co. | SQZB | Downgrade | Hold (Buy) |
0.04 (0.02) |
-50% | Details | |
| 7/19/2023 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 7/12/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 6/22/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2022 | Syros Pharmaceuticals | SYRS | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | MEI Pharma | MEIP | Maintain | Buy (Buy) |
|
Details | ||
| 5/18/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (Buy) |
|
Details | ||
| 4/18/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | MEI Pharma | MEIP | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Syros Pharmaceuticals | SYRS | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2022 | C4 Therapeutics | CCCC | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
| 4/7/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/21/2022 | SQZ Biotechnologies | SQZ | Maintain | Buy (Buy) |
|
Details | ||
| 3/21/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2022 | SQZ Biotechnologies | SQZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/9/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2022 | Intellia Therapeutics | NTLA | Upgrade | Buy (Hold) |
65.04 (17.43) |
-73.2% | Details | |
| 3/7/2022 | Intellia Therapeutics | NTLA | Upgrade | Buy (Hold) |
65.04 (65.04) |
0% | Details | |
| 3/1/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2022 | Intellia Therapeutics | NTLA | New Coverage | Hold (N/A) |
91.42 (17.43) |
-80.93% | Details | |
| 2/14/2022 | Caribou Biosciences Inc. | CRBU | New Coverage | Buy (N/A) |
10.71 (1.92) |
-82.07% | Details | |
| 2/14/2022 | CRISPR Therapeutics | CRSP | Maintain | (N/A) |
|
Details | ||
| 1/31/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | SQZ Biotechnologies | SQZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2022 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2021 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
52.77 (119.24) |
125.96% | Details | |
| 9/7/2021 | SQZ Biotechnologies | SQZ | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2021 | C4 Therapeutics | CCCC | New Coverage | Buy (N/A) |
35.91 (4.35) |
-87.89% | Details | |
| 8/2/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2021 | C4 Therapeutics | CCCC | New Coverage | Buy (N/A) |
37.76 (35.91) |
-4.9% | Details | |
| 6/8/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2021 | SQZ Biotechnologies | SQZ | New Coverage | Buy (N/A) |
12.07 (0.44) |
-96.35% | Details | |
| 2/25/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2021 | Constellation Pharmaceuticals | CNST | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2021 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2021 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
6.11 (3.94) |
-35.52% | Details | |
| 11/25/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Syros Pharmaceuticals | SYRS | New Coverage | Buy (N/A) |
8.89 (0.12) |
-98.65% | Details | |
| 10/23/2020 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
3.28 (9.09) |
177.13% | Details | |
| 10/12/2020 | MEI Pharma | MEIP | New Coverage | Buy (N/A) |
3.08 (2.86) |
-7.14% | Details | |
| 9/3/2020 | Constellation Pharmaceuticals | CNST | New Coverage | Buy (N/A) |
21.18 (33.99) |
60.48% | Details | |
| 7/21/2020 | miRagen Therapeutics | MGEN | New Coverage | Buy (N/A) |
1.06 (23.01) |
2070.75% | Details | |
| 7/13/2020 | Moderna | MRNA | New Coverage | Buy (N/A) |
62.61 (79.77) |
27.41% | Details |
